Viola Ghizzoni

Rome, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 28 publications

Intermittent olaparib with neoadjuvant platinum-based chemotherapy in BRCA-mutated un-resectable ovarian cancer: the NUVOLA trial.

Intermittent olaparib with neoadjuvant platinum-based chemotherapy in BRCA-mutated un-resectable ovarian cancer: the NUVOLA trial.

Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society

Published: March 09, 2026

Homologous recombination deficiency in Ovarian cancer: The game-changer for first-line maintenance therapy.

Homologous recombination deficiency in Ovarian cancer: The game-changer for first-line maintenance therapy.

Journal: Critical reviews in oncology/hematology

Published: September 30, 2025

Homologous recombination repair status in advanced endometrial cancer: an exploratory biomarker analysis from the randomized, phase II MITOEND 3 trial.

Homologous recombination repair status in advanced endometrial cancer: an exploratory biomarker analysis from the randomized, phase II MITOEND 3 trial.

Journal: ESMO open

Published: July 02, 2025

Management of early-stage ovarian cancer: Open questions and debated issues.

Management of early-stage ovarian cancer: Open questions and debated issues.

Journal: Critical reviews in oncology/hematology

Published: September 13, 2024

Relacorilant in recurrent ovarian cancer: clinical evidence and future perspectives.

Relacorilant in recurrent ovarian cancer: clinical evidence and future perspectives.

Journal: Expert review of anticancer therapy

Published: June 11, 2024

Therapeutic Potential of Tisotumab Vedotin in the Treatment of Recurrent or Metastatic Cervical Cancer: A Short Report on the Emerging Data.

Therapeutic Potential of Tisotumab Vedotin in the Treatment of Recurrent or Metastatic Cervical Cancer: A Short Report on the Emerging Data.

Journal: Cancer management and research

Published: April 29, 2023

Survival outcomes in patients with BRCA mutated, variant of unknown significance, and wild type ovarian cancer treated with PARP inhibitors.

Survival outcomes in patients with BRCA mutated, variant of unknown significance, and wild type ovarian cancer treated with PARP inhibitors.

Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society

Published: February 09, 2023

Genome tumor profiling in endometrial cancer and clinical relevance in endometrial cancer management: a retrospective single-center experience.

Genome tumor profiling in endometrial cancer and clinical relevance in endometrial cancer management: a retrospective single-center experience.

Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society

Published: February 06, 2023

Recent progress in the use of pharmacotherapy for endometrial cancer.

Recent progress in the use of pharmacotherapy for endometrial cancer.

Journal: Expert opinion on pharmacotherapy

Published: August 01, 2022

Advanced and recurrent endometrial cancer: State of the art and future perspectives.

Advanced and recurrent endometrial cancer: State of the art and future perspectives.

Journal: Critical reviews in oncology/hematology

Published: April 15, 2022

Combining PARP inhibition and immune checkpoint blockade in ovarian cancer patients: a new perspective on the horizon?

Combining PARP inhibition and immune checkpoint blockade in ovarian cancer patients: a new perspective on the horizon?

Journal: ESMO open

Published: March 17, 2022

Clinical characteristics and molecular aspects of low-grade serous ovarian and peritoneal cancer: a multicenter, observational, retrospective analysis of MITO Group (MITO 22).

Clinical characteristics and molecular aspects of low-grade serous ovarian and peritoneal cancer: a multicenter, observational, retrospective analysis of MITO Group (MITO 22).

Journal: British journal of cancer

Published: February 09, 2022

Showing 1-12 of 28

Last Updated: 09/26/2026